Mary Nallin Omstead

Title: Mary Nallin Omstead: Innovator in Cerebral Drug Delivery

Introduction

Mary Nallin Omstead is a notable inventor based in Acton, MA (US). She has made significant contributions to the field of drug delivery, particularly in enhancing the cerebral bioavailability of medications. Her innovative approach has the potential to improve therapeutic outcomes for patients requiring targeted drug delivery to the brain.

Latest Patents

Mary Nallin Omstead holds a patent for a method and compositions aimed at increasing cerebral bioavailability of blood-born compositions. This patent describes a technique for administering drugs while simultaneously increasing brain nitric oxide (NO) levels. By stimulating the production of NO, particularly through the administration of L-arginine or other agents, cerebral blood flow is enhanced. This increased flow facilitates the delivery of drugs into brain tissue, potentially allowing for lower serum concentrations to achieve desired physiological effects.

Career Highlights

Mary is currently associated with Enos Pharmaceuticals, Inc., where she continues to work on innovative solutions in drug delivery. Her research focuses on overcoming barriers to drug entry into the brain, which is crucial for treating various neurological conditions.

Collaborations

Throughout her career, Mary has collaborated with esteemed colleagues, including Michael A Moskowitz and James K Liao. These partnerships have contributed to her research and the advancement of her patented methods.

Conclusion

Mary Nallin Omstead's work in enhancing cerebral drug delivery represents a significant advancement in medical science. Her innovative methods have the potential to transform how medications are administered for neurological conditions, ultimately improving patient care.